NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-038-2017-0-US-01 NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE US 62/457,720 Abandoned
NCI E-051-2016-0-PCT-02 Method of Sensitizing Cancer Cells to the Cytoxic Effects of Apoptosis Inducing Ligands in Cancer Treatment PCT PCT PCT/US2017/017220 Expired
NIAID E-230-2015-0-PCT-02 RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE PCT PCT PCT/US2017/017038 Expired
NEI E-192-2014-1-IT-01 Surgical Tool and Method for Ocular Tissue Transplantation IT EP 15741462.4 Issued
NEI E-192-2014-1-EP-05 Surgical Tool and Method for Ocular Tissue Transplantation EP National Stage 15741462.4 Issued
NCI E-101-2016-0-CN-03 GENE SIGNATURE PREDICTIVE OF HEPATOCELLULAR CARCINOMA RESPONSE TO TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) CN National Stage 201780018693.9 Issued
NCI E-101-2016-0-PCT-02 GENE SIGNATURE PREDICTIVE OF HEPATOCELLULAR CARCINOMA RESPONSE TO TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) PCT PCT PCT/US2017/016851 Expired
NCI E-101-2016-0-EP-04 GENE SIGNATURE PREDICTIVE OF HEPATOCELLULAR CARCINOMA RESPONSE TO TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION (TACE) EP National Stage 17706618.0 Abandoned
NCI E-234-2014-1-EP-13 METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF EP DIV 17154769.8 Abandoned
NIDDK E-742-2013-0-HK-06 A3 Adenosine Receptor Agonists HK National Stage 17101156.9 Issued
NCI E-080-2008-0-US-06 Human Monoclonal Antibodies Specific for CD22 US CON 15/424,238 10494435 Issued PDF
NCI E-141-2008-0-US-32 Complexes Of IL-15 And IL-15R AIpha And Uses Thereof US CON 15/424,621 10265382 Issued PDF
NIAID E-214-2015-0-US-09 Conformationally Stabilized RSV Pre-Fusion F Proteins US CON 15/424,107 10155023 Issued PDF
NCI E-093-2016-0-PCT-02 Inducible Arginase PCT PCT PCT/US2017/016484 Abandoned
NIDDK E-011-2014-0-HK-12 Piperidine and Piperazine Derivatives and Their Use in Treating Viral Infections and Cancer HK National Stage 171011550.0 Abandoned
NCI E-034-2020-0-US-01 KRAS Peptide Vaccine Compositions And Method Of Use US 62/454,270 Expired
NCI E-056-2011-0-AU-44 The Development And Use Of A Recombinant Brachyury Saccharomyces Cerevisiae (yeast) Vaccine For The Prevention And/or Therapy Of Human Cancer AU DIV 2017200715 Issued
NIEHS E-179-2016-1-US-01 METHODS FOR IMPROVING DRUG DELIVERY ACROSS THE BLOOD-BRAIN-BARRIER US 62/453,718 Abandoned
NIAID E-257-2015-0-PCT-02 COMPOUNDS FOR MODULATING FC-epsilon-RI-beta EXPRESSION AND USES THEREOF PCT PCT PCT/US2017/016042 Expired
NEI E-094-2016-0-US-01 Devices for Tissue Cryopreservation and Recovery US 62/453,148 Abandoned
NCI E-066-2016-0-PCT-02 FULVESTRANT FOR INDUCING IMMUNE-MEDIATED CYTOTOXIC LYSIS
OF CANCER CELLS 		PCT PCT PCT/US17/015829 Expired
NCI E-205-2010-2-JP-10 Photosensitizing Antibody-Flurophore Conjugates JP DIV 2017-13985 Pending
NCI E-173-2018-1-US-01 Viral Methods Of T Cell Therapy US 62/452,081 Abandoned
NICHD E-072-2017-0-US-01 Recombinant Virus Vectors For the Treatment of Glycogen Storage Disease US 62/451,963 Abandoned
NCI E-174-2018-1-US-01 CAS9 Modified TILS For Treatment Of Gastrointestinal Cancer US 62/452,244 Abandoned
NCI E-174-2011-0-AU-16 Pseudomonas Exotoxin A With Less Immunogenic T Cell And/Or B Cell Epitopes AU DIV 2017200541 Issued
NIMH E-174-2006-0-US-14 Intranasal Administration Of Ketamine To Treat Depression US CON 15/417,689 Abandoned
NCI E-190-2014-0-HK-12 VIRUS-LIKE PARTICLE CONJUGATES FOR TREATMENT OF TUMORS HK EP 17100997.4 Issued
NCI E-273-2011-0-US-04 CROSS-REACTIVE ANTIBODIES AGAINST DENGUE VIRUS AND USES THEREOF US DIV 15/416,778 Abandoned
CC E-056-2017-0-US-01 SPATIAL AGGREGATION OF HOLISTICALLY-NESTED CONVOLUTIONAL NEURAL NETWORKS FOR AUTOMATED ORGAN LOCALIZATION AND SEGMENTATION IN 3D MEDICAL SCANS US 62/450,681 Abandoned
NCATS E-046-2018-0-US-01 Autophagy Activation By Novel Inducers Prevents BECN2-mediated Drug Tolerance To Cannabinoids US 62/450,336 Abandoned
NCI E-070-2015-0-US-05 Optimal Dosing Of Heterodimeric Interleukin-15 (IL-15) US National Stage 15/328,882 10335460 Issued PDF
NLM E-125-2017-2-JP-03 CRYSTAL STRUCTURE OF CRISPR CPF1 JP National Stage 2018-557293 Issued
NLM E-125-2017-2-PCT-01 CRYSTAL STRUCTURE OF CRISPR CPF1 PCT PCT COMB PCT/US2017/014568 Expired
NLM E-125-2017-2-US-04 CRYSTAL STRUCTURE OF CRISPR CPF1 US National Stage 16/071,896 Abandoned
NLM E-125-2017-2-EP-02 CRYSTAL STRUCTURE OF CRISPR CPF1 EP National Stage 17704596.0 Pending
NIAID E-123-2007-0-US-34 Monoclonal Antibodies That Neutralize Anthrax Toxins US DIV 15/411,065 10053503 Abandoned PDF
NCI E-230-2011-1-US-07 Vascular Endothelial Growth Factor Antagonist US DIV 15/411,112 10035833 Issued PDF
NINDS E-088-2018-0-EP-01 Anti-HERV-K Envelope Antibody And Uses Thereof FR ORD 17305062.6 Pending
NHLBI E-134-2017-0-US-01 ApoC-llA Mimetic Peptides That Antagonize ApoC-III US 62/448,358 Abandoned
NCI E-245-2014-0-NZ-12 Listeia-based Immunogenic Compositions For Eliciting Anti-tumor Responses NZ National Stage 728391 Abandoned
NCI E-089-2016-0-PCT-02 Niclosamide Therapy For Adrenal Cancer PCT PCT PCT/US2017/013873 Expired
NCI E-159-2014-0-US-03 POLYKETAL PARTICLES INCLUDING A CPG OLIGODEOXYNUCLEOTIDE FOR THE TREATMENT OF LUNG CANCER US National Stage 15/326,387 9919058 Issued PDF
NCI E-008-2014-2-HK-10 Thymic Stromal Lymphopoietin Receptor-Specific Chimeric Antigen Receptors and Methods Using Same HK EP 17100387.2 Issued
NCATS E-066-2017-0-US-01 AMPK Modulators and Methods of Use US 62/445,452 Abandoned
NEI E-192-2014-1-US-02 Surgical Tool For Soft Ocular Tissue Transplantation US National Stage 15/325,584 10729579 Issued PDF
NIA E-027-2005-0-US-09 Methods and Compositions for Modulating Immune Tolerance US DIV 15/404,189 1030-01-15 Issued PDF
NEI E-192-2014-1-JP-07 Surgical Tool and Method for Ocular Tissue Transplantation JP National Stage 2017-501212 Issued
NCI E-151-2011-0-US-04 REDUCTION OF TGF-Beta SIGNALING IN MYELOID CELLS IN THE TREATMENT OF CANCER US DIV 15/402,865 9868954 Abandoned PDF
NCI E-094-2017-0-US-01 Compositions and Methods for Treating Cancer with Anti-Mesothelin Immunotherapy US 62/444,201 Abandoned